Julien Dilly
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 5
- Pancreatic and Hepatic Oncology Research 4
- Cancer Cells and Metastasis 1
-
- Protein Kinase Regulation and GTPase Signaling 5
- PI3K/AKT/mTOR signaling in cancer 2
- Biochemical and Molecular Research 1
- Co-authors
- Andrew J. Aguirre (3 shared papers)Alice Tsang Shaw (1 shared paper)Richard Y. Ebright (1 shared paper)Chloé C. Féral (1 shared paper)Etienne Boulter (1 shared paper)Sabrina Pisano (1 shared paper)Seema Chugh (1 shared paper)K M Guthrie (1 shared paper)
- Journals
- Nature (3 papers)Cancer Discovery (2 papers)Journal of Cell Science (1 paper)Clinical Cancer Research (1 paper)Science (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Julien Dilly
12 papers receiving 687 citations
Julien Dilly's Hit Papers
Peers
Comparison fields: 5 of 50
- Oncology 253
- Cancer Research 108
- Molecular Biology 319
- Cell Biology 41
- Pulmonary and Respiratory Medicine 64
Countries citing papers authored by Julien Dilly
This map shows the geographic impact of Julien Dilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Dilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Dilly more than expected).
Fields of papers citing papers by Julien Dilly
This network shows the impact of papers produced by Julien Dilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Dilly. The network helps show where Julien Dilly may publish in the future.
Co-authors
The 25 scholars most cited alongside Julien Dilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy Hit paper breakdown → | 2024 | 228 |
| 2 | Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer Hit paper breakdown → | 2024 | 152 |
| 3 | Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer Hit paper breakdown → | 2024 | 126 |
| 4 | Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer Hit paper breakdown → | 2024 | 93 |
| 5 | 2023 | 35 | |
| 6 | 2019 | 22 | |
| 7 | 2025 | 19 | |
| 8 | 2025 | 18 | |
| 9 | 2023 | 6 | |
| 10 | 2025 | 3 | |
| 11 | 2026 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2026 | 0 |
About Julien Dilly
Julien Dilly is a scholar working on Oncology, Molecular Biology, Cell Biology, Pathology and Forensic Medicine and Cancer Research, having authored 13 papers that have together received 704 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer Mechanisms and Therapy (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer Cells and Metastasis (1 paper), Biochemical and Molecular Research (1 paper) and Hippo pathway signaling and YAP/TAZ (1 paper). The work is most often cited by research in Oncology (253 citations), Cancer Research (108 citations), Molecular Biology (319 citations), Cell Biology (41 citations) and Pulmonary and Respiratory Medicine (64 citations). Julien Dilly has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Andrew J. Aguirre, Alice Tsang Shaw, Richard Y. Ebright, Chloé C. Féral, Etienne Boulter, Sabrina Pisano, Seema Chugh, K M Guthrie, Mariaelena Pierobon and Carina Shiau. Their work appears in journals such as Nature, Cancer Discovery, Journal of Cell Science, Clinical Cancer Research and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.